Skip to main content

Peer Review reports

From: Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

Original Submission
25 Nov 2019 Submitted Original manuscript
16 Dec 2019 Reviewed Reviewer Report
24 Dec 2019 Reviewed Reviewer Report
26 Dec 2019 Reviewed Reviewer Report
27 Apr 2020 Author responded Author comments - Alison Davie
Resubmission - Version 2
27 Apr 2020 Submitted Manuscript version 2
7 May 2020 Reviewed Reviewer Report
19 May 2020 Reviewed Reviewer Report
20 May 2020 Reviewed Reviewer Report
29 Jul 2020 Author responded Author comments - Alison Davie
Resubmission - Version 3
29 Jul 2020 Submitted Manuscript version 3
Publishing
11 Aug 2020 Editorially accepted
7 Sep 2020 Article published 10.1186/s12885-020-07294-2

You can find further information about peer review here.

Back to article page